Medical Advocates
Ethics and Infectious Diseases
  Ethical Challenges
Screening/Testing
 Refusal of Care/Services
Detention
Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
 HIV Exceptionalism           Conflicts of Interest
Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
 Physician Reimbursement 
Ethics and Disease Challenges and Duties
 HIV Cure
 Ebola Virus Disease
 Executions






 
Ethics Main Page Main New and Noteworthy Home Page

Medical Advocates
Adefovir Dipivoxil (Hepsera)
 
Journal Abstracts, Posters, and
Commentaries

General Reports
 HBV
HBV/HIV
 HIV





 
Adefovir Main Page Main New/Newsworthy Home Page      
Last Update:  May 22, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
                
 
Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis
Buti M, Rodríguez Frías F, Calleja JL, et al
Med Clin (Barc). 2007 Oct 27;129(15):566-70
 Abstract
 
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant
hepatitis B: Final long-term results.
 Schiff E, Lai CL, Hadziyannis S, et al  
 Liver Transpl. 2007 Jan 11;13(3):349-360
 Abstract
 
Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir.
Nekvindova J, Masek V, Veinlichova A, et al 
Xenobiotica. 2006 Dec;36(12):1165-77.
 Abstract
 
Functional involvement of multidrug resistance associated protein 4 (MRP4/ABCC4)
in the renal elimination of the anti-viral drugs, adefovir and tenofovir.
Imaoka T, Kusuhara H, Adachi M, et al 
Mol Pharmacol. 2006 Nov 16;
 Abstract
 
Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil
in healthy Chinese subjects.
Sun DQ, Wang HS, Ni MY, Wang BJ, Guo RC.
Br J Clin Pharmacol. 2006 Jul 21;
 Abstract

Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
 Kearney BP, Ramanathan S, Cheng AK   
J Clin Pharmacol. 2005 Aug;45(8):935-40.
Abstract
HBV/HIV Indications
                
 
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and
HIV infection: ACTG A5127.
 Peters MG, Andersen J, Lynch P, et al
 Hepatology. 2006 Nov;44(5):1110-6
 Abstract
 
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals
co-infected with hepatitis B and HIV.
 Hannon H, Isnard Bagnis C, et al.
Nephrol Dial Transplant. 2004 Feb; 19(2):
 Abstract